NASDAQ:CPRX

Catalyst Pharmaceuticals Stock News

etoro logo Buy CPRX
*Your capital is at risk
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026

Biotech: 3 Profitable Bios Worth Owning

03:22pm, Wednesday, 28'th Dec 2022
The biotechnology space can be a difficult area to generate profits. Drugs take years to develop and often fail FDA approval.
These leading biotech stocks have had a good quarter and some may have room to run, while for others it's time to ring the register. The post Biotech And Medical Stocks Leading Performers As 2022 Draw
HC Wainwright & Co. has decided to maintain its Buy rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) and raise its price target from $18.00 to $24.00. Shares of Catalyst Pharmaceuticals are trading up
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Acquisition Expands The Company’s Commercial Portfolio With An Established U.S. Marketed Product

This Growth Stock's Jaw-Dropping Run-Up Is Smashing Tesla's

09:30pm, Friday, 16'th Dec 2022 The Motley Fool
It's practically printing cash, and even more is on the way.
It's practically printing cash, and even more is on the way.
Top stocks KLA, Super Micro Computer and Catalyst Pharmaceuticals are among sector leaders that are holding their ground. The post Top Stocks: Computer Hardware, Chip Equipment And Biotech Sector Lead

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

01:50pm, Wednesday, 14'th Dec 2022 Zacks Investment Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

Catalyst (CPRX) Up 8.9% Since Last Earnings Report: Can It Continue?

04:30pm, Friday, 09'th Dec 2022 Zacks Investment Research
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE